相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration
W. Michael Caudle et al.
JOURNAL OF NEUROSCIENCE (2007)
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Michelle L. Block et al.
NATURE REVIEWS NEUROSCIENCE (2007)
Nigrostriatal dopamine system dysfunction and subtle motor deficits in manganese-exposed non-human primates
Tomas R. Guilarte et al.
EXPERIMENTAL NEUROLOGY (2006)
An extended simplified reference tissue model for the quantification of dynamic PET with amphetamine challenge
Yun Zhou et al.
NEUROIMAGE (2006)
Translocator protein (18 kDa):: new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function
Vassilios Papadopoulos et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2006)
Microglial activation correlates with severity in Huntington disease - A clinical and PET study
N. Pavese et al.
NEUROLOGY (2006)
Imaging the peripheral benzodiazepine receptor response in central nervous system demyelination and remyelination
Ming-Kai Chen et al.
TOXICOLOGICAL SCIENCES (2006)
Positive immunoreactivity for vesicular monoamine transporter 2 in Lewy bodies and Lewy neurites in substantia nigra
S Yamamoto et al.
NEUROSCIENCE LETTERS (2006)
The Parkinson's complex: Parkinsonism is just the tip of the iceberg
JW Langston
ANNALS OF NEUROLOGY (2006)
Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: A multi-tracer PET study
DJ Doudet et al.
NEUROIMAGE (2006)
In vivo imaging of microglial activation with [11C](R)-PK11195 PET in idiopathic Parkinson's disease
A Gerhard et al.
NEUROBIOLOGY OF DISEASE (2006)
Synaptophysin enhances the neuroprotection of VMAT2 in MPP+-induced toxicity in MN9D cells
CXQ Chen et al.
NEUROBIOLOGY OF DISEASE (2005)
Development of a tracer kinetic plasma input model for (R)-[11C]PK11195 brain studies
MA Kropholler et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2005)
Microglial activation and dopamine terminal loss in early Parkinson's disease
Y Ouchi et al.
ANNALS OF NEUROLOGY (2005)
The role of radiotracer imaging in Parkinson disease
B Ravina et al.
NEUROLOGY (2005)
α-Synuclein regulation of the dopaminergic transporter:: a possible role in the pathogenesis of Parkinson's disease
A Sidhu et al.
FEBS LETTERS (2004)
Microglial response is poorly correlated with neurodegeneration following chronic, low-dose MPTP administration in monkeys
SD Hurley et al.
EXPERIMENTAL NEUROLOGY (2003)
Impact of psycho stimulants on vesicular monoamine transporter function
AE Fleckenstein et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2003)
Morphogenesis of Lewy bodies: Dissimilar incorporation of alpha-synuclein, ubiquitin, and p62
E Kuusisto et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2003)
Imaging end points for monitoring neuroprotection in Parkinson's disease
DJ Brooks
ANNALS OF NEUROLOGY (2003)
Pathogenesis of Parkinson's disease:: Dopamine, vesicles and α-synuclein
J Lotharius et al.
NATURE REVIEWS NEUROSCIENCE (2002)
Vesicle permeabilization by protofibrillar α-synuclein is sensitive to Parkinson's disease-linked mutations and occurs by a pore-like mechanism
MJ Volles et al.
BIOCHEMISTRY (2002)
Formation and removal of α-synuclein aggregates in cells exposed to mitochondrial inhibitors
HJ Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Progression of dopaminergic degeneration in Parkinson's disease and atypical parkinsonism: A longitudinal beta-CIT SPECT study
W Pirker et al.
MOVEMENT DISORDERS (2002)
Vesicle permeabilization by protofibrillar α-synuclein:: Implications for the pathogenesis and treatment of Parkinson's disease
MJ Volles et al.
BIOCHEMISTRY (2001)